American Journal of Obstetrics & Gynecology
Volume 201, Issue 5 , Pages 456.e1-456.e5 , November 2009

Expanding access to intrauterine contraception

  • Rebecca H. Allen, MD, MPH

      Affiliations

    • Department of Obstetrics and Gynecology, Women & Infants Hospital, Providence, RI
    • ,
  • Alisa B. Goldberg, MD, MPH

      Affiliations

    • Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, and Planned Parenthood League of Massachusetts, Boston, MA
    • ,
  • David A. Grimes, MD

      Affiliations

    • Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, and Family Health International, Research Triangle Park, NC

Received 29 October 2008 ,Revised 5 March 2009 ,Accepted 16 April 2009.

References 

  1. Thonneau PF, Almont T. Contraceptive efficacy of intrauterine devices. Am J Obstet Gynecol. 2008;198:248–253
  2. d'Arcangues C. Worldwide use of intrauterine devices for contraception. Contraception. 2007;75:S2–S7
  3. Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data. 2004;350:1–36
  4. Hubacher D. The checkered history and bright future of intrauterine contraception in the United States. Perspect Sex Reprod Health. 2002;34:98–103
  5. Stanwood NL, Garrett JM, Konrad TR. Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice. Obstet Gynecol. 2002;99:275–280
  6. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38:90–96
  7. Speidel JJ, Harper CC, Shields WC. The potential of long-acting reversible contraception to decrease unintended pregnancy. Contraception. 2008;78:197–200
  8. Grimes DA, Mishell DR. Intrauterine contraception as an alternative to interval tubal sterilization. Contraception. 2008;77:6–9
  9. Hillis SD, Marchbanks PA, Tylor LR, Peterson HB. Poststerilization regret: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol. 1999;93:889–895
  10. World Health Organization. Medical eligibility criteria for contraceptive use. 3rd ed.. Geneva: World Health Organization; 2004;
  11. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 59, January 2005. Intrauterine device. Obstet Gynecol. 2005;105:223–232
  12. Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. FSRH Guidance (November 2007) Intrauterine Contraception [Internet]: Royal College of Obstetricians and Gynaecologists, 2007 [cited 2008 Oct. 28]. www.ffprhc.org.ukAccessed Oct. 28, 2008
  13. Cramer DW, Schiff I, Schoenbaum SC, et al. Tubal infertility and the intrauterine device. N Engl J Med. 1985;312:941–947
  14. Daling JR, Weiss NS, Metch BJ, et al. Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med. 1985;312:937–941
  15. Hubacher D. Copper intrauterine device use by nulliparous women: review of side effects. Contraception. 2007;75:S8–S11
  16. Prager S, Darney PD. The levonorgestrel intrauterine system in nulliparous women. Contraception. 2007;75:S12–S15
  17. Grimes DA, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev. 2001;CD001327
  18. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet. 1992;339:785–788
  19. Hubacher D, Lara-Ricalde R, Taylor DJ, Guerra-Infante F, Guzman-Rodriguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med. 2001;345:561–567
  20. Grimes DA. Intrauterine devices and infertility: sifting through the evidence. Lancet. 2001;358:6–7
  21. Murty J. Use and effectiveness of oral analgesia when fitting an intrauterine device. J Fam Plann Reprod Health Care. 2003;29:150–151
  22. Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol. 2006;195:1272–1277
  23. Suhonen S, Haukkamaa M, Jakobsson T, Rauramo I. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception. 2004;69:407–412
  24. Saav I, Aronsson A, Marions L, Stephansson O, Gemzell-Danielsson K. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod. 2007;22:2647–2652
  25. Oloto E, Bromham D, Murty J. Pain and discomfort perception at IUD insertion-effect of short-duration, low-volume, intracervical application of two percent lignocain gel (Instillagel)—a preliminary study. Br J Fam Plann. 1996;22:177–180
  26. Jensen HH, Blaabjerg J, Lyndrup J. Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion. Ugeskr Laeger. 1998;160:6958–6961
  27. Farmer M, Webb A. Intrauterine device insertion-related complications: can they be predicted?. J Fam Plann Reprod Health Care. 2003;29:227–231
  28. Harrison-Woolrych M, Ashton J, Coulter D. Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?. Contraception. 2003;67:53–56
  29. Grimes DA. Intrauterine devices. In:  Hatcher R,  Trussell J,  Nelson A,  Cates W,  Stewart F,  Kowal D editor. Contraceptive technology. 19th ed.. New York: Ardent Media, Inc; 2007;
  30. Otero-Flores JB, Guerrero-Carreno FJ, Vazquez-Estrada LA. A comparative randomized study of three different IUDs in nulliparous Mexican women. Contraception. 2003;67:273–276
  31. Sivin I. Problems in the conduct and analysis of “a comparative randomized study of three different IUDs in nulliparous Mexican women.”. Contraception. 2004;69:259–260
  32. Sivin I, Stern J. Long-acting, more effective copper T IUDs: a summary of U.S. experience, 1970-75. Stud Fam Plann. 1979;10:263–281
  33. Grimes DA, Hubacher D, Lopez LM, Schulz KF. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev. 2006;CD006034
  34. Abma JC, Martinez GM, Mosher WD, Dawson BS. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2002. Vital Health Stat. 2004;23:1–48
  35. Stevens-Simon C, Kelly L, Kulick R. A village would be nice but…it takes a long-acting contraceptive to prevent repeat adolescent pregnancies. Am J Prev Med. 2001;21:60–65
  36. Zibners A, Cromer BA, Hayes J. Comparison of continuation rates for hormonal contraception among adolescents. J Pediatr Adolesc Gynecol. 1999;12:90–94
  37. Stanwood NL, Bradley KA. Young pregnant women's knowledge of modern intrauterine devices. Obstet Gynecol. 2006;108:1417–1422
  38. Whitaker AK, Johnson LM, Harwood B, Chiappetta L, Creinin MD, Gold MA. Adolescent and young adult women's knowledge of and attitudes toward the intrauterine device. Contraception. 2008;78:211–217
  39. Rivera R, Chen-Mok M, McMullen S. Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD. Contraception. 1999;60:155–160
  40. Diaz J, Pinto Neto AM, Bahamondes L, Diaz M, Arce XE, Castro S. Performance of the copper T 200 in parous adolescents: are copper IUDs suitable for these women?. Contraception. 1993;48:23–28
  41. Zhang J, Feldblum PJ, Chi IC, Farr MG. Risk factors for copper T IUD expulsion: an epidemiologic analysis. Contraception. 1992;46:427–433
  42. Luukkainen T, Allonen H, Haukkamaa M, et al. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. Contraception. 1987;36:169–179
  43. Thonneau P, Almont T, de La Rochebrochard E, Maria B. Risk factors for IUD failure: results of a large multicentre case-control study. Hum Reprod. 2006;21:2612–2616
  44. Sivin I. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol. 1991;78:291–298
  45. ACOG Committee Opinion No. 392: Intrauterine device and adolescents. Obstet Gynecol. 2007;110:1493–1495
  46. Toma A, Jamieson MA. Revisiting the intrauterine contraceptive device in adolescents. J Pediatr Adolesc Gynecol. 2006;19:291–296
  47. Walsh T, Grimes D, Frezieres R, et al. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices (IUD Study Group). Lancet. 1998;351:1005–1008
  48. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2006. Atlanta, GA: US Department of Health and Human Services; 2007;
  49. Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? (a systematic review). Contraception. 2006;73:145–153
  50. Faundes A, Telles E, Cristofoletti ML, Faundes D, Castro S, Hardy E. The risk of inadvertent intrauterine device insertion in women carriers of endocervical Chlamydia trachomatis. Contraception. 1998;58:105–109
  51. Skjeldestad FE, Halvorsen LE, Kahn H, Nordbo SA, Saake K. IUD users in Norway are at low risk for genital C. trachomatis infection. Contraception. 1996;54:209–212
  52. Stewart F, Trussell J, Van Look P. Emergency contraception. In:  Hatcher R,  Trussell J,  Nelson A editor. Contraceptive technology. 19th ed.. New York: Ardent Media, Inc; 2007;
  53. FFPRHC Guidance (April 2004). The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health. J Fam Plann Reprod Health Care. 2004;30:99–108quiz 109
  54. World Health Organization. Selected practice recommendations for contraceptive use. 2nd ed.. Geneva: World Health Organization; 2004;
  55. Ogburn JA, Espey E, Stonehocker J. Barriers to intrauterine device insertion in postpartum women. Contraception. 2005;72:426–429
  56. Celen S, Moroy P, Sucak A, Aktulay A, Danisman N. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception. 2004;69:279–282
  57. Grimes D, Schulz K, Van Vliet H, Stanwood N. Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev. 2003;CD003036
  58. Chi IC, Farr G. Postpartum IUD contraception—a review of an international experience. Adv Contracept. 1989;5:127–146
  59. Hayes JL, Cwiak C, Goedken P, Zieman M. A pilot clinical trial of ultrasound-guided postplacental insertion of a levonorgestrel intrauterine device. Contraception. 2007;76:292–296
  60. O'Hanley K, Huber DH. Postpartum IUDS: keys for success. Contraception. 1992;45:351–361
  61. Xu JX, Rivera R, Dunson TR, et al. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China. Contraception. 1996;54:33–38
  62. Celen S, Moroy P, Sucak A, Aktulay A, Danisman N. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception. 2004;69:279–282
  63. Grimes D, Schulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev. 2004;CD001777
  64. Goodman S, Hendlish SK, Benedict C, Reeves MF, Pera-Floyd M, Foster-Rosales A. Increasing intrauterine contraception use by reducing barriers to post-abortal and interval insertion. Contraception. 2008;78:136–142
  65. Gillett PG, Lee NH, Yuzpe AA, Cerskus I. A comparison of the efficacy and acceptability of the Copper-7 intrauterine device following immediate or delayed insertion after first-trimester therapeutic abortion. Fertil Steril. 1980;34:121–124
  66. Goodman S, Hendlish SK, Reeves MF, Foster-Rosales A. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception. 2008;78:143–148
  67. Harper CC, Blum M, de Bocanegra HT, et al. Challenges in translating evidence to practice: the provision of intrauterine contraception. Obstet Gynecol. 2008;111:1359–1369
  68. Grimes DA, Hubacher D. IUDs: time for a renaissance. Am Fam Physician. 1998;58:1963–1964
  69. Hwang AC, Grimes DA, Shields WC. Universal insurance coverage for contraceptives: a public health imperative. Contraception. 2004;70:357–358

 Reprints not available from the authors.

 Cite this article as: Allen RH, Goldberg AB, Grimes DA. Expanding access to intrauterine contraception. Am J Obstet Gynecol 2009;201:456.e1-5.

PII: S0002-9378(09)00425-6

doi: 10.1016/j.ajog.2009.04.027

American Journal of Obstetrics & Gynecology
Volume 201, Issue 5 , Pages 456.e1-456.e5 , November 2009

Article Tools